Interleukin-1 production (IL-1 production)

"IL‑1 production" refers to the cellular and molecular processes leading to synthesis and secretion of interleukin 1 family cytokines, primarily interleukin 1 alpha (IL‑1α) and interleukin 1 beta (IL‑1β). These cytokines are produced by various cell types—most notably macrophages, monocytes, dendritic cells, fibroblasts, epithelial cells—and play central roles in mediating inflammation and immune responses. Production involves gene transcription triggered by stimuli such as infection or tissue damage; translation into precursor proteins; proteolytic processing—especially for pro–IL–1β via inflammasome activation—and subsequent secretion. The released cytokines act locally or systemically to induce fever, promote leukocyte recruitment through endothelial activation and increased vascular permeability, stimulate acute phase protein synthesis in the liver, amplify adaptive immunity by promoting lymphocyte proliferation/activation, and regulate other inflammatory mediators. Dysregulated IL–1 production is implicated in autoinflammatory diseases and chronic inflammatory conditions. Note on correctness: “Interleukin 1 production” is not a canonical therapeutic target but rather describes a biological process involving multiple molecules. Therapeutic targets related to this pathway include individual cytokines such as “Interleukin 1 beta” or their receptors (“Interleukin 1 receptor”). For structured data purposes you should use these specific entities instead of “production.”